DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 64 filers reported holding DESIGN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,673,240 | -69.9% | 2,403,915 | -19.7% | 0.00% | -100.0% |
| Q2 2023 | $18,862,523 | +2.6% | 2,994,051 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $18,382,592 | -48.9% | 3,185,891 | -9.2% | 0.00% | 0.0% |
| Q4 2022 | $35,992,328 | -40.2% | 3,508,024 | -2.5% | 0.00% | -50.0% |
| Q3 2022 | $60,177,000 | +21.4% | 3,599,125 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $49,559,000 | -2.6% | 3,539,936 | +12.3% | 0.00% | +100.0% |
| Q1 2022 | $50,887,000 | +7.3% | 3,150,820 | +42.2% | 0.00% | 0.0% |
| Q4 2021 | $47,438,000 | +146.0% | 2,215,624 | +68.8% | 0.00% | 0.0% |
| Q3 2021 | $19,282,000 | -30.9% | 1,312,664 | -6.5% | 0.00% | 0.0% |
| Q2 2021 | $27,911,000 | +18.0% | 1,403,342 | +77.4% | 0.00% | 0.0% |
| Q1 2021 | $23,652,000 | – | 791,019 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $15,402,483 | 7.89% |
| Logos Global Management LP | 5,032,501 | $11,876,702 | 1.58% |
| Prosight Management, LP | 1,203,745 | $2,840,838 | 0.90% |
| TANG CAPITAL MANAGEMENT LLC | 1,350,000 | $3,186,000 | 0.45% |
| Soleus Capital Management, L.P. | 1,025,000 | $2,419,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,512,986 | $5,930,647 | 0.12% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 180,000 | $425,000 | 0.09% |
| Corton Capital Inc. | 27,134 | $64,036 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,722 | $237,704 | 0.03% |
| Rock Springs Capital Management LP | 460,391 | $1,086,523 | 0.03% |